Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complexities of adjuvant endocrine therapy in young premenopausal women.

Oncology (Williston Park, N.Y.) - 1 May 2009

Henry N Lynn, Griggs Jennifer J

Abstract excerpt

Overall, this excellent overview of management issues for breast cancer patients under 40 years of age highlights the major questions surrounding choices of adjuvant systemic therapy. Treatment choices are dependent on breast cancer biology (receptor status) as well as patient factors (ovarian function and desire for future fertility). As many unanswered questions remain, it is important to continue to enroll...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amenorrhea
Share to Breast Neoplasms
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Premenopause

Share to Selective Estrogen Receptor Modulators

Share to Tamoxifen

Source

Identifiers

PMID: 19544688

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complexities of adjuvant endocrine therapy in young premenopausal women.PMID 19544688Read ↗

Fertility preservation and breast cancer: A complex problem.Semantic proximity Read ↗

Next-Generation Endocrine Therapies for Breast Cancer.Semantic proximity Read ↗

Management of breast cancer in young patients involves complicated surgical, genetic, and fertility issues.Semantic proximity Read ↗

Breast cancer in women under 40.Semantic proximity Read ↗

Diagnosis and Treatment of Breast Cancer in Young Women.Semantic proximity Read ↗

Chemoprevention options for BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.Semantic proximity Read ↗

Breast cancer before age 40 years.Semantic proximity Read ↗

Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer.Semantic proximity Read ↗

Estrogen receptor-beta and breast cancer: Translating biology into clinical practiceSemantic proximity Read ↗

Exogenous reproductive hormone use in breast cancer survivors and previvors.Semantic proximity Read ↗

Hormonal management after risk-reducing surgery in BRCA-mutated triple-negative breast cancer survivors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.